comparemela.com

Latest Breaking News On - Division of brain sciences - Page 2 : comparemela.com

Companies Smashing the Psychedelic Ceiling

Companies Smashing the Psychedelic Ceiling
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Awakn Life Sciences Corp : Awakn Life Sciences Appoints Addiction Expert Prof David Nutt as Chief Research Officer

Awakn Life Sciences Corp : Awakn Life Sciences Appoints Addiction Expert Prof David Nutt as Chief Research Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Awakn Life Sciences Appoints Addiction Expert Prof David Nutt as Chief Research Officer

Awakn Life Sciences Appoints Addiction Expert Prof David Nutt as Chief Research Officer
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics

Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced today that the Company has partnered with Microdose Psychedelic Insights a leader in B2B psychedelic intelligence, to present a free, three-part live video discussion series titled “Mydecine Speaker … The first Mydecine Carhart Roscow Yeji Lee, Business Insider reporter, the panelists will discuss the impact of cutting edge research in mainstream medical interest about unlocking the potential of psychedelic therapies

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.